NOS3 and endothelial dysfunction: Interestingly, previous in vitro studies showed that FABP4 can inhibit the insulin and endothelial nitric oxide synthase (eNOS)-signaling pathways and can lead to endothelial dysfunction in human umbilical vein endothelial cells (HUVECs) [18].